The Latest
More in Neuromuscular


Neuromuscular Notes: Hereditary Neuropathy

It is becoming increasingly important to establish a molecular genetic diagnosis.

Trisha Multhaupt-Buell, MS, CGC; and Reza Sadjadi, MD

Cover Focus

Muscle Cramps

Reliable and validated outcome measures and new treatments are needed.

Hans D. Katzberg, MD, MSc, FRCPC; and Hamid Sadeghian, MD, FRCPC

Cover Focus

Differential Diagnosis of Distal Myopathies

The era of clinical molecular genetics has refined diagnosis and will hopefully lead to disease-modifying treatments.

Kevin J. Felice, DO

Cover Focus

Noninflammatory Myopathies

As genetic diagnosis increases, noninflammatory myopathies are being seen more in clinical practice.

Yessar Hussain, MD; Krishna Pokala, MD; and Nancy Kuo, MS, MD

Cover Focus

Sporadic Inclusion Body Myositis

An update on pathophysiology with diagnostic and treatment implications.

Matthew Varon, MD; and Pedro M. Machado, MD, PhD

Cover Focus

Congenital Myasthenic Syndrome Treatment

Heterogeneity makes diagnosis and treatment challenging.

Stanley Jones P. Iyadurai, MD, PhD, FAAN

Cover Focus

Spinal Muscular Atrophy

A devastating disease now has 2 approved breakthrough treatments available.

Wijdan Rai, MD; and Bakri Elsheikh, MBBS

Cover Focus

Myasthenia Gravis Treatment

Both symptomatic and maintenance treatments are available.

Thy Nguyen, MD; and Cecile L. Phan, MD

Cover Focus

Amyotrophic Lateral Sclerosis

Integrated care provides the best quality of life.

Jonathan R. Brent, MD, PhD; and Senda Ajroud-Driss, MD

Cover Focus

Utility of Skin Biopsy in Neuromuscular Disease

Intraepidermal nerve fiber density finding can help diagnose small fiber neuropathy.

David S. Saperstein, MD

Cover Focus


Evaluation for elevated creatine kinase is a required skill for neurologists.

Nicholas J. Silvestri, MD; and Gil I. Wolfe, MD

Cover Focus

Genetic Testing in Neuromuscular Disorders

Understanding ordering and interpretation of genetic tests is paramount for clinical management.

James P. Orengo, MD, PhD; and David R. Murdock, MD

Guest Medical Editor's Page

Neuromuscular Disease: Dynamic Progress at Work

With 7 new treatments in 5 years, including some of the first approved gene therapies, the field of neuromuscular disorders is making rapid dynamic progress.

Aziz Shaibani, MD


Neuromuscular Notes: Autoantibodies in Immune Myopathies

Antibody testing results provide clinically useful information.

Emer R. McGrath, MB, PhD


Neuromuscular Notes: Genetics of Amyotrophic Lateral Sclerosis

Genetic discovery and the promise of gene therapy create hope for effective treatments and eventual prevention.

Katharine Nicholson, MD

Case Report

Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis

When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.

Daniel L. Menkes, MD; and Amanda E. Simon, BS

Guest Medical Editor's Page

The Importance of Sleep

Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.

Logan Schneider, MD


Hometown Highlights: Congenital Myasthenic Syndromes

With careful diagnosis, treatment can improve symptoms of congenital myasthenic syndromes.

Andrew G. Engel, MD

Special Report

2018 Drug and Device Approvals for Neurology

Spotlight Topic: Neuropsychiatry

Cognitive Complaints and Neuropsychologic Testing

When should neuropsychologic tests be ordered and what questions should testing answer?

Nabil Ali, MD; Laura M. Clark, PhD, ABPP; and Kendra Corning, PsyD, HSPP

Show More